Dear Dr. Roach: In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn't tell us how to ...
Among pediatric and adult patients with cystic fibrosis, the average number of chronic respiratory therapies used fell after ...
In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with nine more pharmaceutical companies.
The companies were the latest to agree to sell drugs to Medicaid and directly to consumers at discounted prices. President ...
Use of inhaled corticosteroids by pregnant mothers with asthma may protect infants against reduced lung function at 4 to 6 weeks of age.
The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...
The US FDA has approved depemokimab as an add-on maintenance therapy for individuals aged 12 years or older with severe asthma, according to a press release from manufacturer GlaxoSmithKline.
Helping an older adult stay consistent with breathing treatments can feel like a full-time job - especially when COPD, asthma ...
The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...
You likely use them every single day - but some of your home appliances could be emitting harmful pollutants, according to a ...
The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback